🇺🇸 Bio-Rad Laboratories, Inc.
Forum topic · BIO · Company page: financials, ownership and filings
Join the discussion on Bio-Rad Laboratories, Inc.
Loading…
Results announced on 4 November 2026
Bio-Rad Laboratories, Inc. announced results on 4 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $656 million (up 1% from a year earlier) and net income of $459 million.
Mutual funds: 315 funds hold $2.9 billion
315 mutual funds in 2 countries hold shares of Bio-Rad Laboratories, Inc. worth $2.9 billion, about 32.1% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 129 funds added shares and 136 sold; on balance they sold $108 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.